Immunoglobulin deficiency in children with Hib vaccine failure

Vaccine

Volumn 29, Issue 49, 2011, Pages 9137-9140

  Ladhani, Shamez ^a,b   Oeser, Clarissa ^b   Sheldon, Joanne ^b   Ramsay, Mary ^a   Booy, Robert ^c   Heath, Paul T ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Immunoglobulin deficiency; Invasive Hib disease; Vaccine failure

Indexed keywords

BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN M;

AGE; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ARTICLE; CELLULITIS; CHILD; DISEASE SEVERITY; DISEASE SURVEILLANCE; EPIGLOTTITIS; FEMALE; FOLLOW UP; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT INFECTION; RISK FACTOR; VACCINE FAILURE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; CHILD; CHILD, PRESCHOOL; DYSGAMMAGLOBULINEMIA; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; INFANT; LOGISTIC MODELS; MALE; POPULATION SURVEILLANCE; PREVALENCE;

EID: 82555169597     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.107     Document Type: Article

References (19)

1. Heath P.T., Booy R., Azzopardi H.J., Slack M.P., Bowen-Morris J., Griffiths H., et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000, 284:2334-2340.
2. Heath P.T., Booy R., Griffiths H., Clutterbuck E., Azzopardi H.J., Slack M.P., et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000, 31:973-980.
3. Ballow M., Notarangelo L., Grimbacher B., Cunningham-Rundles C., Stein M., Helbert M., et al. Immunodeficiencies. Clin Exp Immunol 2009, 158(Suppl. 1):14-22.
4. Fried A.J., Bonilla F.A. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev 2009, 22:396-414.
5. Holmes S.J., Granoff D.M. The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis 1992, 165(Suppl. 1):S121-S128.
6. Breukels M.A., Spanjaard L., Sanders L.A., Rijkers G.T. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin Infect Dis 2001, 32:1700-1705.
7. Breukels M.A., Jol-van der Z.E., van Tol M.J., Rijkers G.T. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin Infect Dis 2002, 34:191-197.
8. Auckland C., Gray S., Borrow R., Andrews N., Goldblatt D., Ramsay M., et al. Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis 2006, 194:1745-1752.
9. Whelan M.A., Hwan W.H., Beausoleil J., Hauck W.W., McGeady S.J. Infants presenting with recurrent infections and low immunoglobulins: characteristics and analysis of normalization. J Clin Immunol 2006, 26:7-11.
10. Kilic S.S., Tezcan I., Sanal O., Metin A., Ersoy F. Transient hypogammaglobulinemia of infancy: clinical and immunologic features of 40 new cases. Pediatr Int 2000, 42:647-650.
11. Walker A.M., Kemp A.S., Hill D.J., Shelton M.J. Features of transient hypogammaglobulinaemia in infants screened for immunological abnormalities. Arch Dis Child 1994, 70:183-186.
12. Moschese V., Graziani S., Avanzini M.A., Carsetti R., Marconi M., La R.M., et al. A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol 2008, 21:343-352.
13. Ladhani S., Heath P.T., Aibara R.J., Ramsay M.E., Slack M.P., Hibberd M.L., et al. Long-term complications and risk of other serious infections following invasive Haemophilus influenzae serotype b disease in vaccinated children. Vaccine 2010, 28:2195-2200.
14. Ladhani S., Heath P.T., Ramsay M.E., Slack M.P., Kibwana E., Pollard A.J., et al. Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom. Clin Infect Dis 2009, 49:372-380.
15. Phipps D.C., West J., Eby R., Koster M., Madore D.V., Quataert S.A. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990, 135:121-128.
16. Milford Ward A., Sheldon J., Rowbotom A Wild GD. PRU handbook of Clinical Immunochemistry 2007, United Kingdom PRU Publications, Sheffield. 9th ed.
17. Holmes S.J., Lucas A.H., Osterholm M.T., Froeschle J.E., Granoff D.M. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. JAMA 1991, 266:1960-1965. The Collaborative Study Group.
18. Ladhani S., Borrow R., Heath P.T., Ramsay M.E., Booy R. Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure. Vaccine 2010, 28:4440-4444.
19. Ladhani S., Slack M.P., Heys M., White J., Ramsay M.E. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 2008, 93:665-669.